US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist

18.880
-2.920-13.39%

Close Jun 14 16:00 ET

19.260
+0.380+2.01%

Post 19:59 ET

1.09BMarket Cap-6031P/E (TTM)

Cullinan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-31.50%42.99M

44.28%190.65M

39.49%45.49M

50.52%44.8M

1.34%37.61M

92.17%62.76M

52.06%132.14M

-5.06%32.61M

61.99%29.77M

123.48%37.11M

Selling and administrative expenses

15.79%12.34M

5.73%42.49M

-5.76%10.64M

8.88%10.98M

-4.50%10.21M

31.26%10.66M

37.89%40.19M

-16.20%11.29M

77.10%10.09M

121.61%10.7M

-General and administrative expense

15.79%12.34M

5.73%42.49M

-5.76%10.64M

8.88%10.98M

-4.50%10.21M

31.26%10.66M

37.89%40.19M

-16.20%11.29M

77.10%10.09M

121.61%10.7M

Research and development costs

-41.17%30.65M

61.13%148.16M

63.44%34.85M

71.85%33.82M

3.71%27.39M

112.32%52.1M

59.21%91.95M

2.12%21.32M

55.21%19.68M

124.24%26.41M

Operating profit

31.50%-42.99M

-44.28%-190.65M

-39.49%-45.49M

-50.52%-44.8M

-1.34%-37.61M

-92.17%-62.76M

-94.45%-132.14M

5.06%-32.61M

-61.99%-29.77M

-123.48%-37.11M

Net non-operating interest income expense

26.29%5.69M

227.14%21.63M

75.89%5.92M

149.89%5.88M

663.56%5.32M

2,188.32%4.51M

1,285.95%6.61M

2,355.47%3.36M

1,894.07%2.35M

302.89%697K

Non-operating interest income

26.29%5.69M

227.14%21.63M

75.89%5.92M

149.89%5.88M

663.56%5.32M

2,188.32%4.51M

1,285.95%6.61M

2,355.47%3.36M

1,894.07%2.35M

302.89%697K

Other net income (expense)

-141.12%-44K

-100.07%-201K

-139.26%-117K

-260K

-99.98%69K

107K

3,460,625.00%276.84M

7,350.00%298K

3,456,900.00%276.54M

Special income (charges)

----

-100.16%-440K

--0

---440K

--0

----

--276.79M

--0

--276.79M

-Less:Impairment of capital assets

----

--440K

--0

--440K

----

--0

----

-Gain on sale of business

----

--0

----

--276.79M

--0

--276.79M

Other non- operating income (expenses)

-141.12%-44K

319.30%239K

-139.26%-117K

--180K

128.63%69K

--107K

812.50%57K

7,350.00%298K

----

-2,912.50%-241K

Income before tax

35.78%-37.34M

-211.83%-169.22M

-37.10%-39.69M

-42.94%-39.18M

-113.41%-32.21M

-79.12%-58.14M

324.22%151.32M

15.38%-28.95M

-50.13%-27.41M

1,560.76%240.14M

Income tax

-133.53%-14.12M

-660.06%-14.12M

42.12M

-1.86M

-2.52M

66.07M

Net income

35.78%-37.34M

-242.04%-155.1M

5.63%-25.56M

-57.42%-39.18M

-118.51%-32.21M

-350.99%-58.14M

261.81%109.2M

20.81%-27.09M

-36.32%-24.89M

1,158.85%174.07M

Net income continuous Operations

35.78%-37.34M

-242.04%-155.1M

5.63%-25.56M

-57.42%-39.18M

-118.51%-32.21M

-350.99%-58.14M

261.81%109.2M

20.81%-27.09M

-36.32%-24.89M

1,158.85%174.07M

Minority interest income

-7.26%-192K

3.96%-1.94M

-475.16%-1.76M

77.46%-179K

-5.43%-2.02M

81.91%-306K

90.54%-86K

-3.74%-833K

Net income attributable to the parent company

35.91%-37.15M

-237.72%-153.16M

11.12%-23.8M

-57.97%-39.18M

-118.42%-32.21M

-379.10%-57.96M

269.61%111.21M

17.63%-26.78M

-42.96%-24.8M

1,218.56%174.9M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

35.91%-37.15M

-237.72%-153.16M

11.12%-23.8M

-57.97%-39.18M

-118.42%-32.21M

-379.10%-57.96M

269.61%111.21M

17.63%-26.78M

-42.96%-24.8M

1,218.56%174.9M

Basic earnings per share

39.44%-0.86

-250.00%-3.69

8.47%-0.54

-68.52%-0.91

-121.03%-0.82

-425.93%-1.42

261.84%2.46

20.27%-0.59

-35.00%-0.54

1,183.33%3.9

Diluted earnings per share

39.44%-0.86

-255.04%-3.69

8.47%-0.54

-68.52%-0.91

-121.75%-0.82

-425.93%-1.42

256.58%2.38

20.27%-0.59

-35.00%-0.54

1,147.22%3.77

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-31.50%42.99M	44.28%190.65M	39.49%45.49M	50.52%44.8M	1.34%37.61M	92.17%62.76M	52.06%132.14M	-5.06%32.61M	61.99%29.77M	123.48%37.11M
Selling and administrative expenses	15.79%12.34M	5.73%42.49M	-5.76%10.64M	8.88%10.98M	-4.50%10.21M	31.26%10.66M	37.89%40.19M	-16.20%11.29M	77.10%10.09M	121.61%10.7M
-General and administrative expense	15.79%12.34M	5.73%42.49M	-5.76%10.64M	8.88%10.98M	-4.50%10.21M	31.26%10.66M	37.89%40.19M	-16.20%11.29M	77.10%10.09M	121.61%10.7M
Research and development costs	-41.17%30.65M	61.13%148.16M	63.44%34.85M	71.85%33.82M	3.71%27.39M	112.32%52.1M	59.21%91.95M	2.12%21.32M	55.21%19.68M	124.24%26.41M
Operating profit	31.50%-42.99M	-44.28%-190.65M	-39.49%-45.49M	-50.52%-44.8M	-1.34%-37.61M	-92.17%-62.76M	-94.45%-132.14M	5.06%-32.61M	-61.99%-29.77M	-123.48%-37.11M
Net non-operating interest income expense	26.29%5.69M	227.14%21.63M	75.89%5.92M	149.89%5.88M	663.56%5.32M	2,188.32%4.51M	1,285.95%6.61M	2,355.47%3.36M	1,894.07%2.35M	302.89%697K
Non-operating interest income	26.29%5.69M	227.14%21.63M	75.89%5.92M	149.89%5.88M	663.56%5.32M	2,188.32%4.51M	1,285.95%6.61M	2,355.47%3.36M	1,894.07%2.35M	302.89%697K
Other net income (expense)	-141.12%-44K	-100.07%-201K	-139.26%-117K	-260K	-99.98%69K	107K	3,460,625.00%276.84M	7,350.00%298K		3,456,900.00%276.54M
Special income (charges)	----	-100.16%-440K	--0	---440K	--0	----	--276.79M	--0	--0	--276.79M
-Less:Impairment of capital assets	----	--440K	--0	--440K	----	----	--0	--0	--0	----
-Gain on sale of business	----	--0	--0	--0	--0	----	--276.79M	--0	--0	--276.79M
Other non- operating income (expenses)	-141.12%-44K	319.30%239K	-139.26%-117K	--180K	128.63%69K	--107K	812.50%57K	7,350.00%298K	----	-2,912.50%-241K
Income before tax	35.78%-37.34M	-211.83%-169.22M	-37.10%-39.69M	-42.94%-39.18M	-113.41%-32.21M	-79.12%-58.14M	324.22%151.32M	15.38%-28.95M	-50.13%-27.41M	1,560.76%240.14M
Income tax		-133.53%-14.12M	-660.06%-14.12M	0	0		42.12M	-1.86M	-2.52M	66.07M
Net income	35.78%-37.34M	-242.04%-155.1M	5.63%-25.56M	-57.42%-39.18M	-118.51%-32.21M	-350.99%-58.14M	261.81%109.2M	20.81%-27.09M	-36.32%-24.89M	1,158.85%174.07M
Net income continuous Operations	35.78%-37.34M	-242.04%-155.1M	5.63%-25.56M	-57.42%-39.18M	-118.51%-32.21M	-350.99%-58.14M	261.81%109.2M	20.81%-27.09M	-36.32%-24.89M	1,158.85%174.07M
Minority interest income	-7.26%-192K	3.96%-1.94M	-475.16%-1.76M	0	0	77.46%-179K	-5.43%-2.02M	81.91%-306K	90.54%-86K	-3.74%-833K
Net income attributable to the parent company	35.91%-37.15M	-237.72%-153.16M	11.12%-23.8M	-57.97%-39.18M	-118.42%-32.21M	-379.10%-57.96M	269.61%111.21M	17.63%-26.78M	-42.96%-24.8M	1,218.56%174.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	35.91%-37.15M	-237.72%-153.16M	11.12%-23.8M	-57.97%-39.18M	-118.42%-32.21M	-379.10%-57.96M	269.61%111.21M	17.63%-26.78M	-42.96%-24.8M	1,218.56%174.9M
Basic earnings per share	39.44%-0.86	-250.00%-3.69	8.47%-0.54	-68.52%-0.91	-121.03%-0.82	-425.93%-1.42	261.84%2.46	20.27%-0.59	-35.00%-0.54	1,183.33%3.9
Diluted earnings per share	39.44%-0.86	-255.04%-3.69	8.47%-0.54	-68.52%-0.91	-121.75%-0.82	-425.93%-1.42	256.58%2.38	20.27%-0.59	-35.00%-0.54	1,147.22%3.77
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall